Hanson McClain Advisors »

Mirati Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.3k 107 58.76
2023-09-30 $3.5k 80 43.56
2023-03-31 $817 22 37.18
2022-09-30 $0 6 0.00
2022-06-30 $10k 154 64.94
2021-09-30 $12k 70 171.43